| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | -0.31 | 0.1 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.1 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.066 | 0.1 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |